This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xiong, Y. Q. Articles by Bayer, A. S. Search for Related Content PubMed PubMed Citation Articles by Xiong, Y. Q. Articles by Bayer, A. S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2005, p. 380-387, Vol. 49, No. 1
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.1.380-387.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Real-Time In Vivo Bioluminescent Imaging for Evaluating the Efficacy of Antibiotics in a Rat Staphylococcus aureus Endocarditis Model

Department of Medicine, Division of Infectious Diseases, Harbor-UCLA Research and Education Institute, Torrance,¹ Geffen School of Medicine, University of California Los Angeles, Los Angeles,² Xenogen Corp., Alameda California³

Received 3 June 2004/ Returned for modification 1 August 2004/ Accepted 30 August 2004

Therapeutic options for invasive Staphylococcus aureus infections have become limited due to rising antimicrobial resistance, making relevant animal model testing of new candidate agents more crucial than ever. In the present studies, a rat model of aortic infective endocarditis (IE) caused by a bioluminescently engineered, biofilm-positive S. aureus strain was used to evaluate real-time antibiotic efficacy directly. This strain was vancomycin and cefazolin susceptible but gentamicin resistant. Bioluminescence was detected and quantified daily in antibiotic-treated and control animals with IE, using a highly sensitive in vivo imaging system (IVIS). Persistent and increasing cardiac bioluminescent signals (BLS) were observed in untreated animals. Three days of vancomycin therapy caused significant reductions in both cardiac BLS (>10-fold versus control) and S. aureus densities in cardiac vegetations (P < 0.005 versus control). However, 3 days after discontinuation of vancomycin therapy, a greater than threefold increase in cardiac BLS was observed, indicating relapsing IE (which was confirmed by quantitative culture). Cefazolin resulted in modest decreases in cardiac BLS and bacterial densities. These microbiologic and cardiac BLS differences during therapy correlated with a longer time-above-MIC for vancomycin (>12 h) than for cefazolin (4 h). Gentamicin caused neither a reduction in cardiac S. aureus densities nor a reduction in BLS. There were significant correlations between cardiac BLS and S. aureus densities in vegetations in all treatment groups. These data suggest that bioluminescent imaging provides a substantial advance in the real-time monitoring of the efficacy of therapy of invasive S. aureus infections in live animals.

This article has been cited by other articles:

• Brady, R. A., Leid, J. G., Kofonow, J., Costerton, J. W., Shirtliff, M. E. (2007). Immunoglobulins to Surface-Associated Biofilm Immunogens Provide a Novel Means of Visualization of Methicillin-Resistant Staphylococcus aureus Biofilms. Appl. Environ. Microbiol. 73: 6612-6619 [Abstract] [Full Text]  
• Peerschke, E. I. B., Bayer, A. S., Ghebrehiwet, B., Xiong, Y. Q. (2006). gC1qR/p33 Blockade Reduces Staphylococcus aureus Colonization of Target Tissues in an Animal Model of Infective Endocarditis.. Infect. Immun. 74: 4418-4423 [Abstract] [Full Text]